2022 annual financial data
Eupraxia Pharmaceuticals 2022 Revenue growth
Direct answer
Revenue growth was Not calculable.
Operating income was -17,617,452 USD and net income was -18,489,629 USD.
Operating cash flow was -14,395,201 USD.
Get free Eupraxia Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -17,617,452 USD
- Net income
- -18,489,629 USD
- Operating cash flow
- -14,395,201 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Eupraxia Pharmaceuticals financial years